HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pleurotus ostreatus, an edible mushroom, enhances glucose 6-phosphate dehydrogenase, ascorbate peroxidase and reduces xanthine dehydrogenase in major organs of aged rats.

AbstractCONTEXT:
Aging is now considered to be associated with an elevation in oxidative damage to macromolecules and enhanced levels of inflammation. Therefore, inhibition of age-related oxidative stress by natural supplement is an important study.
OBJECTIVES:
To investigate whether the treatment with Pleurotus ostreatus (Jacq.: Fr) Kumm, (Pleurotaceae) can ameliorate oxidative damage in aged rats.
MATERIALS AND METHODS:
Male Wistar rats were divided into three groups of six each: group 1, normal young rats; group 2, normal aged untreated rats; group 3, normal aged rats treated with P. ostreatus (200 mg/kg body wt administered intraperitoneally for 21 days). On the 22nd day, rats were sacrificed by decapitation; the liver, kidneys, heart and brain were removed from each rat for the biochemical and isozyme analyses of the antioxidant enzymes glucose 6-phosphate dehydrogenase (G6PDH), ascorbate peroxidase (Apx) and xanthine dehydrogenase (XDH).
RESULTS:
An elevated activity of XDH was observed in the liver (G2:13.72 ± 4.1 versus G1: 7.57 ± 1.15; p < 0.05), kidneys (G2:101.48 ± 12.3 versus G1: 31.15 ± 1.71; p < 0.01), heart (G2: 63.21 ± 3.96 versus G1: 37.3 ± 2.70; p < 0.01) and brain (G2: 39.02 ± 3.96 versus G1: 19.84 ± 1.22; p < 0.001). The activities of G6PDH and Apx were lowered in major organs of aged untreated rats. However, treatment of P. ostreatus to aged rats resulted in decreased XDH and increased G6PDH and Apx activities in liver, kidneys, heart and brain. Interestingly, analyses of isozyme pattern of these enzymes are support the results obtained from the spectrophotometric determinations.
CONCLUSION:
These results suggest that an extract of P. ostreatus can protect the age-related oxidative damage in major organs of Wistar rats by enhancing the antioxidant enzymes G6PDH and Apx and by reducing XDH.
AuthorsPhilip Aloysius Thomas, Pitchairaj Geraldine, Thanasekaran Jayakumar
JournalPharmaceutical biology (Pharm Biol) Vol. 52 Issue 5 Pg. 646-54 (May 2014) ISSN: 1744-5116 [Electronic] England
PMID24392756 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antioxidants
  • Glucosephosphate Dehydrogenase
  • Ascorbate Peroxidases
  • Xanthine Dehydrogenase
Topics
  • Aging (drug effects, metabolism)
  • Animals
  • Antioxidants (isolation & purification, pharmacology)
  • Ascorbate Peroxidases (metabolism)
  • Brain (drug effects, enzymology)
  • Enzyme Activation (drug effects)
  • Glucosephosphate Dehydrogenase (metabolism)
  • Heart (drug effects)
  • Kidney (drug effects, enzymology)
  • Liver (drug effects, enzymology)
  • Male
  • Oxidative Stress (drug effects)
  • Pleurotus (chemistry)
  • Rats, Wistar
  • Xanthine Dehydrogenase (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: